CClinicalTrials.gg
WithdrawnNCT00697489Updated Apr 8, 2013

Treatment of Urinary Stress Incontinence During or Following Correction of Pelvic Organ Prolapse

A Phase 4 interventional study of correction of POP plus preventive continence procedure and POP surgery followed by eventual incontinence procedure in Pelvic Organ Prolapse, sponsored by University Magna Graecia. Withdrawn at 1 site in Italy. Open to female participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2013-04-08.

Sponsored by University Magna Graecia · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
Female
01

Study summary

The incidence of pelvic organ prolapse (POP) in parous women is estimated over 50%. A variety of urinary, bowel and sexual symptoms may be associated with POP. Moreover, a proportion of women who underwent a surgical correction of POP may occur post-surgical urinary incontinence and, thus, if this last presents as genuine stress-type or mixed-type, a second surgical intervention may be required. At this proposal, with the aim to reduce the incidence of postoperative urinary incontinence, the addition of a preventive continence procedure to a POP repair intervention has been widely proposed, but the potential benefits needs to be balanced against potential disadvantages.

Based on these considerations, the aim of this trial will be to compare two different surgical strategies for women with POP without urinary stress incontinence. Specifically, the efficacy to associate and to follow a preventive continence procedure to the correction of POP will be compared.

Read the detailed description

Women with POP not associated to urinary stress incontinence will be enrolled and randomized in two arms(groups A and B). Patients of group A will be treated with unique surgery (correction of POP plus preventive continence procedure), whereas in patients of group B POP will be surgically corrected and, in case of stress or mixed postoperative incontinence, a further intervention for urinary stress incontinence will be tailored.

All patients eligible will undergo baseline assessment consisting of anthropometric, clinical, hormonal, ultrasonographic and urodynamic evaluations. During the study, the clinical outcomes, and the adverse experience will be evaluated in each patient.

Data will be analyzed using the intention-to-treat principle and a P value of 0.05 or less will be considered significant.

02

Conditions studied

  • Pelvic Organ Prolapse

Keywords

  • Pelvic organ prolapse
  • Urinary incontinence
  • Mesh
03

In context

Urinary Incontinence, Stress

658 studies on the registry are indexed under Urinary Incontinence, Stress; 123 are open to participants now.

Browse Urinary Incontinence, Stress studies →

Lead sponsor

University Magna Graecia is the lead sponsor of 75 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Pelvic organ prolapse stage 2-3
  • Absence of subjective urinary stress incontinence

Exclusion criteria

Exclusion Criteria:

  • pregnancy
  • \<12 months postpartum
  • systemic disease known to affect bladder function
  • current chemotherapy or radiation therapy
  • urethral diverticulum, augmentation cytoplasty, or artificial sphincter
  • recent pelvic surgery
  • patient age under 18 and over 80
  • any previous pelvic surgery, diabetes mellitus and collagen disease
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Active comparator
    1

    unique surgery

    Procedure: correction of POP plus preventive continence procedure

  • Active comparator
    2

    Double surgery

    Procedure: POP surgery followed by eventual incontinence procedure

Interventions

  • Procedurecorrection of POP plus preventive continence procedure
  • ProcedurePOP surgery followed by eventual incontinence procedure
06

What researchers measure

Primary outcomes

  1. efficacy (cure rate)

    Time frame: 12 months

Secondary outcomes

  1. intra-operative complication rate

    Time frame: one day

  2. postoperative complications rate

    Time frame: 12 months

  3. sexual function

    Time frame: 12 months

  4. quality of life

    Time frame: 12 months

  5. Failure rate

    Time frame: 12 months

  6. Recurrence rate

    Time frame: 12 months

07

Study locations

1 site
  • "Pugliese" Hospital
    Catanzaro, 88100, Italy
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 8, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00697489
Lead sponsor
University Magna Graecia
Responsible party
Stefano Palomba (Associate Professor, University Magna Graecia) — Principal investigator
First posted
Jun 16, 2008
Start date
Jun 2008
Primary completion
Aug 2010
Last update
Apr 8, 2013

Study contacts

Stefano Palomba, MD
principal investigator · Chair of Obstetrics and Gynecology, University "Magna Graecia" of Catanzaro
Fulvio Zullo, MD
study chair · Chair of Obstetrics and Gynecology, University "Magna Graecia" of Catanzaro

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Apr 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion